Cargando…
Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions
BACKGROUND: Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline. Current drugs can only relieve symptoms, but cannot really cure AD. Cerebralcare Granule® (CG) is a Traditional Chinese medicine (TCM) containing a variety of biolo...
Autores principales: | Qiao, Ou, Zhang, Xinyu, Zhang, Yi, Ji, Haixia, Li, Zhi, Han, Xiaoying, Wang, Wenzhe, Li, Xia, Wang, Juan, Liu, Changxiao, Gao, Wenyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240384/ https://www.ncbi.nlm.nih.gov/pubmed/34183022 http://dx.doi.org/10.1186/s13020-021-00456-9 |
Ejemplares similares
-
Neuroprotective effect of Cerebralcare Granule after cerebral ischemia/reperfusion injury
por: Zhang, Xiao-xiao, et al.
Publicado: (2016) -
Cerebralcare Granule(®) attenuates cognitive impairment in rats continuously overexpressing microRNA-30e
por: XU, YONG, et al.
Publicado: (2015) -
Mechanism of Cerebralcare Granule® for Improving Cognitive Function in Resting-State Brain Functional Networks of Sub-healthy Subjects
por: Li, Jing, et al.
Publicado: (2017) -
Efficacy of Memantine Hydrochloride in Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
por: Wang, Qiu-Jun, et al.
Publicado: (2020)